Search Results - "Cellini, Claudia"

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study by Cavo, Michele, Prof, Tacchetti, Paola, MD, Patriarca, Francesca, MD, Petrucci, Maria Teresa, MD, Pantani, Lucia, MD, Galli, Monica, MD, Di Raimondo, Francesco, Prof, Crippa, Claudia, MD, Zamagni, Elena, MD, Palumbo, Antonio, MD, Offidani, Massimo, MD, Corradini, Paolo, Prof, Narni, Franco, MD, Spadano, Antonio, MD, Pescosta, Norbert, MD, Deliliers, Giorgio Lambertenghi, Prof, Ledda, Antonio, MD, Cellini, Claudia, MD, Caravita, Tommaso, MD, Tosi, Patrizia, MD, Baccarani, Michele, Prof

“…Summary Background Thalidomide plus dexamethasone (TD) is a standard induction therapy for myeloma. We aimed to assess the efficacy and safety of addition of…”
Get full text

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial by Bringhen, Sara, D'Agostino, Mattia, Paris, Laura, Ballanti, Stelvio, Pescosta, Norbert, Spada, Stefano, Pezzatti, Sara, Grasso, Mariella, Rota-Scalabrini, Delia, De Rosa, Luca, Pavone, Vincenzo, Gazzera, Giulia, Aquino, Sara, Poggiu, Marco, Santoro, Armando, Gentile, Massimo, Baldini, Luca, Petrucci, Maria Teresa, Tosi, Patrizia, Marasca, Roberto, Cellini, Claudia, Palumbo, Antonio, Falco, Patrizia, Hájek, Roman, Boccadoro, Mario, Larocca, Alessandra

“…n the EMN01 trial, the addition of an alkylator (melphalan or cyclophosphamide) to lenalidomide-steroid induction therapy was prospectively evaluated in…”
Get full text

Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study by CAVO, Michele, TOSI, Patrizia, NARNI, Franco, CARUBELLI, Affra, MASINI, Luciano, CATALANO, Lucio, FIACCHINI, Mauro, DE VIVO, Antonio, GOZZETTI, Alessandro, LAZZARO, Antonio, TURA, Sante, BACCARANI, Michele, ZAMAGNI, Elena, CELLINI, Claudia, TACCHETTI, Paola, PATRIARCA, Francesca, DI RAIMONDO, Francesco, VOLPE, Ettore, RONCONI, Sonia, CANGINI, Delia

“…We performed a prospective, randomized study of single (arm A) versus double (arm B) autologous stem-cell transplantation (ASCT) for younger patients with…”
Get full text

Impact of Gain and Amplification of 1q in Newly Diagnosed Multiple Myeloma Patients Receiving Carfilzomib-Based Treatment in the Forte Trial by D'Agostino, Mattia, Ruggeri, Marina, Aquino, Sara, Giuliani, Nicola, Arigoni, Maddalena, Gentile, Massimo, Olivero, Martina, Vincelli, Iolanda Donatella, Capra, Andrea, Mussatto, Chiara, Ledda, Antonio, Tacchetti, Paola, Musolino, Caterina, Cellini, Claudia, Patriarca, Francesca, Ballanti, Stelvio, Calogero, Raffaele, Musto, Pellegrino, Boccadoro, Mario, Gay, Francesca

“…Background Copy-number alterations of chromosome 1q are frequently found in multiple myeloma (MM) and are associated with poor prognosis. Recently, it has been…”
Get full text

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi by Zaja, Francesco, Ferrero, Simone, Stelitano, Caterina, Ferrari, Angela, Salvi, Flavia, Arcari, Annalisa, Musuraca, Gerardo, Botto, Barbara, Spina, Michele, Cellini, Claudia, Patti, Caterina, Liberati, Anna M, Minotto, Claudia, Pileri, Stefano A, Ceccarelli, Manuela, Volpetti, Stefano, Ferranti, Antonella, Drandi, Daniela, Montechiarello, Elisa, Ladetto, Marco, Carmichael, James, Fanin, Renato

Get full text

Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study by Zannetti, Beatrice Anna, Saraceni, Francesco, Cellini, Claudia, Fabbri, Elisabetta, Monaco, Federica, Guarini, Attilio, Laszlo, Daniele, Martino, Massimo, Olivieri, Attilio, Imola, Manuela, Tosi, Patrizia, Chiarucci, Martina, Zuffa, Eliana, Lanza, Francesco

“…•Autologous stem cell transplantation is the standard of care for multiple myeloma.•The optimal stem cell mobilization strategy remains a matter of…”
Get full text

Efficacy and Feasibility of Dose/Schedule-Adjusted Rd-R Vs. Continuous Rd in Elderly and Intermediate-Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients: RV-MM-PI-0752 Phase III Randomized Study by Larocca, Alessandra, Salvini, Marco, De Paoli, Lorenzo, Cascavilla, Nicola, Benevolo, Giulia, Galli, Monica, Montefusco, Vittorio, Caravita di Toritto, Tommaso, Baraldi, Anna, Spada, Stefano, Giuliani, Nicola, Pautasso, Chiara, Pulini, Stefano, Ronconi, Sonia, Pescosta, Norbert, Liberati, Anna Marina, Patriarca, Francesca, Cellini, Claudia, Tosi, Patrizia, Offidani, Massimo, Cavo, Michele, Palumbo, Antonio, Boccadoro, Mario, Bringhen, Sara

“…INTRODUCTION: Elderly patients with newly diagnosed multiple myeloma (NDMM) are highly heterogeneous and their outcome is influenced by many factors: beside…”
Get full text

Randomized Trial of Fludarabine Versus Fludarabine and Idarubicin as Frontline Treatment in Patients With Indolent or Mantle-Cell Lymphoma by ZINZANI, P. L, MAGAGNOLI, M, LAUTA, V. M, BENDANDI, M, GHERLINZONI, F, GENTILINI, P, CICCONE, F, CELLINI, C, STEFONI, V, RICCIUTI, F, GOBBI, M, TURA, S, MORETTI, L, DE RENZO, A, BATTISTA, R, ZACCARIA, A, GUARDIGNI, L, MAZZA, P, MARRA, R, RONCONI, F

“…A first comparative trial of fludarabine (FLU) alone versus FLU plus idarubicin (FLU-ID) for indolent or mantle-cell lymphomas. From September 1995 to July…”
Get full text

Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti‐idiotype vaccination by Motta, Maria R., Castellani, Samantha, Rizzi, Simonetta, Curti, Antonio, Gubinelli, Francesco, Fogli, Miriam, Ferri, Elisa, Cellini, Claudia, Baccarani, Michele, Lemoli, Roberto M.

“…Circulating monocytes from multiple myeloma patients enrolled in a clinical study of anti‐idiotype vaccination were labelled with clinical‐grade anti‐CD14…”
Get full text

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma by Larocca, Alessandra, Bonello, Francesca, Gaidano, Gianluca, D'Agostino, Mattia, Offidani, Massimo, Cascavilla, Nicola, Capra, Andrea, Benevolo, Giulia, Tosi, Patrizia, Galli, Monica, Marasca, Roberto, Giuliani, Nicola, Bernardini, Annalisa, Antonioli, Elisabetta, Rota-Scalabrini, Delia, Cellini, Claudia, Pompa, Alessandra, Monaco, Federico, Patriarca, Francesca, Caravita di Toritto, Tommaso, Corradini, Paolo, Tacchetti, Paola, Boccadoro, Mario, Bringhen, Sara

“…Lenalidomide-dexamethasone (Rd) is standard treatment for elderly patients with multiple myeloma (MM). In this randomized phase 3 study, we investigated…”
Get full text

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial by Mina, Roberto, Musto, Pellegrino, Rota-Scalabrini, Delia, Paris, Laura, Gamberi, Barbara, Palmas, Angelo, Aquino, Sara, de Fabritiis, Paolo, Giuliani, Nicola, De Rosa, Luca, Gozzetti, Alessandro, Cellini, Claudia, Bertamini, Luca, Capra, Andrea, Oddolo, Daniela, Vincelli, Iolanda Donatella, Ronconi, Sonia, Pavone, Vincenzo, Pescosta, Norbert, Cea, Michele, Fioritoni, Francesca, Ballanti, Stelvio, Grasso, Mariella, Zamagni, Elena, Belotti, Angelo, Boccadoro, Mario, Gay, Francesca

“…Patients with newly diagnosed multiple myeloma and high-risk cytogenetic abnormalities (HRCA) represent an unmet medical need. In the FORTE trial, lenalidomide…”
Get full text

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma by Cavo, Michele, Zamagni, Elena, Tosi, Patrizia, Tacchetti, Paola, Cellini, Claudia, Cangini, Delia, de Vivo, Antonio, Testoni, Nicoletta, Nicci, Chiara, Terragna, Carolina, Grafone, Tiziana, Perrone, Giulia, Ceccolini, Michela, Tura, Sante, Baccarani, Michele

“…The aim of the present study was to compare thalidomide-dexamethasone (Thal-Dex) and vincristine-doxorubicin-dexamethasone (VAD) as primary therapy in…”
Get full text

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma by D’Agostino, Mattia, Bertuglia, Giuseppe, Rota-Scalabrini, Delia, Belotti, Angelo, Morè, Sonia, Corradini, Paolo, Oliva, Stefania, Ledda, Antonio, Grasso, Mariella, Pavone, Vincenzo, Ronconi, Sonia, Vincelli, Iolanda Donatella, Ballanti, Stelvio, Velluti, Cristina, Cellini, Claudia, Gozzetti, Alessandro, Palmas, Angelo D., Gamberi, Barbara, Mancuso, Katia, Paris, Laura, Zambello, Renato, Petrucci, Maria Teresa, Bruno, Benedetto, Musto, Pellegrino, Gay, Francesca

“…•Amp(1q), HRCA ≥2, high CTC levels, and a longer time to reach first MRD negativity are significant predictors of unsustained MRD negativity.•Maintenance…”
Get full text

Carfilzomib-Lenalidomide-Dexamethasone (KRd) Vs. Lenalidomide-Dexamethasone (Rd) in Newly Diagnosed Fit or Intermediate-Fit Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation (Phase III EMN20 Trial): Analysis of Sustained Undetectable Minimal Residual Disease (MRD) by Bringhen, Sara, Antonioli, Elisabetta, Gamberi, Barbara, Bruno, Benedetto, Derudas, Daniele, Tosi, Patrizia, Fazio, Francesca, Mazza, Rita, Ronconi, Sonia, Corradini, Paolo, Lotti, Flavia, Cellini, Claudia, Falcone, Antonietta Pia, Galieni, Piero, Ria, Roberto, Belotti, Angelo, Mannina, Donato, Cafro, Anna Maria, Cangialosi, Clotilde, Vincelli, Iolanda Donatella, Lombardo, Alessandra, Larocca, Alessandra, Boccadoro, Mario, D'Agostino, Mattia

“…Background. Before the recent introduction of daratumumab (Dara) in the frontline setting, lenalidomide-dexamethasone (Rd) has represented a standard of care…”
Get full text

Late Hematologic Recovery after CPX-351 Induction Chemotherapy in AML: Predictive Disease and Patient's Factors and Their Impact on Survival by Rondoni, Michela, Minetto, Paola, Puglisi, Bruna, Saraceni, Francesco, Brunetti, Lorenzo, Mianulli, Anna Maria, Bocchia, Monica, Santoni, Adele, Riva, Carola, Giannini, Barbara, Monaco, Federica, Zannetti, Beatrice, Cellini, Claudia, Nicoletti, Annalisa, Valenti, Anna Maria, Capelli, Debora, Raspadori, Donatella, Olivieri, Attilio, Lanza, Francesco, Graziano, Claudio, Tosi, Patrizia, Lemoli, Roberto Massimo, Guolo, Fabio

“…In a randomized Phase III trial, CPX-351has shown to be more effective than conventional 3+7 chemotherapy as frontline treatment for secondary or…”
Get full text

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial by PALUMBO, Antonio, CAVO, Michele, NOZZOLI, Chiara, RIA, Roberto, MARASCA, Roberto, MONTEFUSCO, Vittorio, BALDINI, Luca, ELICE, Francesca, CALLEA, Vincenzo, PULINI, Stefano, CARELLA, Angelo M, ZAMBELLO, Renato, BRINGHEN, Sara, BENEVOLO, Giulia, MAGAROTTO, Valeria, TACCHETTI, Paola, PESCOSTA, Norbert, CELLINI, Claudia, POLLONI, Claudia, EVANGELISTA, Andrea, CARAVITA, Tommaso, MORABITO, Fortunato, OFFIDANI, Massimo, ZAMAGNI, Elena, TOSI, Patrizia, BOCCADORO, Mario, ROMANO, Alessandra, PATRIARCA, Francesca, ROSSI, Davide, GENTILINI, Fabiana, CRIPPA, Claudia, GALLI, Monica

“…In patients with myeloma, thalidomide significantly improves outcomes but increases the risk of thromboembolic events. In this randomized, open-label,…”
Get full text

MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial by Ferreri, Andrés J M, Doorduijn, Jeanette K, Re, Alessandro, Cabras, Maria Giuseppina, Smith, Jeffery, Ilariucci, Fiorella, Luppi, Mario, Calimeri, Teresa, Cattaneo, Chiara, Khwaja, Jahanzaib, Botto, Barbara, Cellini, Claudia, Nassi, Luca, Linton, Kim, McKay, Pam, Olivieri, Jacopo, Patti, Caterina, Re, Francesca, Fanni, Alessandro, Singh, Vikram, Bromberg, Jacoline E C, Cozens, Kelly, Gastaldi, Elisabetta, Bernardi, Massimo, Cascavilla, Nicola, Davies, Andrew, Fox, Christopher P, Frezzato, Maurizio, Osborne, Wendy, Liberati, Anna Marina, Novak, Urban, Zambello, Renato, Zucca, Emanuele, Cwynarski, Kate

“…Secondary CNS lymphoma is a rare but potentially lethal event in patients with diffuse large B-cell lymphoma. We aimed to assess the activity and safety of an…”
Get full text

Efficacy and Safety of Ixazomib Induction and Maintenance in Newly Diagnosed Multiple Myeloma Patients According to the IMWG Frailty Score: A Post-Hoc Analysis of the EMN10-Unito Trial by Mina, Roberto, Larocca, Alessandra, Offidani, Massimo, Innao, Vanessa, Cellini, Claudia, Galli, Monica, Cetani, Giusy, Grasso, Mariella, Ciccone, Giovannino, Capra, Andrea, Aquino, Sara, Priola, Claudia, Margiotta Casaluci, Gloria, De Sabbata, Giovanni, Ballanti, Stelvio, Cavo, Michele, Boccadoro, Mario, Bringhen, Sara

“…INTRODUCTION. Elderly patients (pts) with newly diagnosed multiple myeloma (NDMM) are a heterogeneous population. The IMWG frailty score stratifies pts ≥65…”
Get full text

Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma by Zucca, Emanuele, Ceriani, Luca, Davies, Andrew S., Ciccone, Giovannino, Ricardi, Umberto, Di Rocco, Alice, Kryachok, Iryna, Botto, Barbara, Balzarotti, Monica, Tucci, Alessandra, Zilioli, Vittorio Ruggero, Usai, Sara, Arcaini, Luca, Pennese, Elsa, Dabrowska-Iwanicka, Anna, Ferreri, Andrés José María, Merli, Franceso, Zhao, Wei Li, Hodgson, David, Ionescu, Codruta, Rigacci, Luigi, Cellini, Claudia, Stelitano, Caterina, Volpetti, Stefano, Minoia, Carla, Spina, Michele, Fossa, Alexander, Mikhaeel, George, Cwynarski, Kate, Janikova, Andrea, Stepanishyna, Yana, Jerkeman, Mats, Huettmann, Andreas, da Silva, Maria Gomes, Stevens, Don A., Barrington, Sally F, Małkowski, Bogdan, Metser, Ur, Versari, Annibale, Chauvie, Stephane, Bagni, Oreste, Cozens, Kelly, Perticone, Sonia, Ielmini, Nicoletta, Deantonio, Letizia, Walewski, Jan, Trneny, Marek, Gospodarowicz, Mary, Cavalli, Franco, Johnson, Peter, Martelli, Maurizio

“…Background:Primary mediastinal B-cell lymphoma (PMBCL) is clinically and biologically distinct from other types of aggressive lymphoma, it is characterized by…”
Get full text

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results by Martelli, Maurizio, Ceriani, Luca, Ciccone, Giovannino, Ricardi, Umberto, Kriachok, Iryna, Botto, Barbara, Balzarotti, Monica, Tucci, Alessandra, Usai, Sara Veronica, Zilioli, Vittorio Ruggero, Pennese, Elsa, Arcaini, Luca, Dabrowska-Iwanicka, Anna, Ferreri, Andrés J M, Merli, Francesco, Zhao, Weili, Rigacci, Luigi, Cellini, Claudia, Hodgson, David, Ionescu, Codruta, Minoia, Carla, Lucchini, Elisa, Spina, Michele, Fosså, Alexander, Janikova, Andrea, Cwynarski, Kate, Mikhaeel, George, Jerkeman, Mats, Di Rocco, Alice, Stepanishyna, Yana, Vitolo, Umberto, Santoro, Armando, Re, Alessandro, Puccini, Benedetta, Olivieri, Jacopo, Petrucci, Luigi, Barrington, Sally F, Malkowski, Bogdan, Metser, Ur, Versari, Annibale, Chauvie, Stephane, Walewski, Jan, Trneny, Marek, Cavalli, Franco, Gospodarowicz, Mary, Johnson, Peter W M, Davies, Andrew, Zucca, Emanuele

“…The role of consolidation radiotherapy in patients with primary mediastinal B-cell lymphoma (PMBCL) is controversial. The IELSG37 trial, a randomized…”
Get full text